CLDI · Calidi Biotherapeutics, Inc. · Exempt Offerings
$0.70
-0.07 (-8.74%)
At close · Oct 22
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company estimates that based on the Company's liquidity resources, there is substantial doubt about the Company's ability to continue as a going concern within 12 months from the date of issuance of these unaudited condensed consolidated financial statements.”View the 10-Q filed Aug 13, 2026
Market Cap
$1.98M
Shares
2.58M
Volume · Oct 22
112.08K
Avg daily vol (58 sessions)
150.32K
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2024-06-06 | New | Biotechnology | $5,549,588 | $5,549,588 | 06b |
| 2024-03-21 | New | Biotechnology | $341,250 | $195,000 | 06b |
| 2024-03-21 | New | Biotechnology | $10,000 | $10,000 | 06b |
| 2024-03-21 | New | Biotechnology | $65,000 | $32,500 | 06b |
| 2024-03-21 | New | Biotechnology | $3,500,000 | $3,500,000 | 06b |
| 2024-03-21 | New | Biotechnology | $1,000,000 | $1,000,000 | 06b |
Showing 1–6 of 6 filings